Home Biosimilar Antibodies GPCR & G Protein Others antibody Erenumab (Anti-CALCRL / CGRPR) For research use only.
Not for use in humans.

Erenumab (Anti-CALCRL / CGRPR)

Synonyms:

Erenumab (Anti-CALCRL/CGRPR) is a fully human monoclonal antibody targeting CGRP receptor (calcitonin gene–related peptide receptor). Erenumab can be used for the prevention of episodic migraine. MW:145.5 KD.

Erenumab (Anti-CALCRL / CGRPR)

Purity & Quality Control

≥99

Biological Activity

Description Erenumab (Anti-CALCRL/CGRPR) is a fully human monoclonal antibody targeting CGRP receptor (calcitonin gene–related peptide receptor). Erenumab can be used for the prevention of episodic migraine. MW:145.5 KD.

Product Details

CAS No. 1582205-90-0
Molecular Weight 145.5 kDa
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Erenumab (Anti-CALCRL / CGRPR) | Erenumab (Anti-CALCRL / CGRPR) supplier | purchase Erenumab (Anti-CALCRL / CGRPR) | Erenumab (Anti-CALCRL / CGRPR) cost | Erenumab (Anti-CALCRL / CGRPR) manufacturer | order Erenumab (Anti-CALCRL / CGRPR) | Erenumab (Anti-CALCRL / CGRPR) distributor